Karen L. Parkhill - 18 Mar 2022 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & Chief Financial Officer
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Issuer symbol
MDT
Transactions as of
18 Mar 2022
Net transactions value
-$75,020
Form type
4
Filing time
21 Mar 2022, 19:34:45 UTC
Previous filing
07 Dec 2021
Next filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Sale $75,020 -682 -1.9% $110.00 34,946 18 Mar 2022 Direct F1, F2
holding MDT Ordinary Shares 843 18 Mar 2022 By Child #1
holding MDT Ordinary Shares 843 18 Mar 2022 By Child #2
holding MDT Ordinary Shares 843 18 Mar 2022 By Child #3
holding MDT Ordinary Shares 49,859 18 Mar 2022 Jeffrey S. Parkhill 2021 Irrevocable Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This balance increased by 182 shares due to exempt transactions such as dividend reinvestment.
F3 These shares are held in the Jeffrey S. Parkhill 2021 Irrevocable Trust, of which the insider is the trustee and a beneficiary.